Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model": Down's syndrome

被引：15

作者：

Goi, G.

Baquero-Herrera, C.

Licastro, F.

Dogliotti, G.

Corsi, M. M. ^{[1
]}

机构：

[1] Univ Milan, Clin Pathol Lab, Inst Gen Pathol, Milan, Italy

[2] Univ Milan, Dept Med Chem, Milan, Italy

[3] Univ Bologna, Immunol Sect, Dept Expt Pathol, Bologna, Italy

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2006年 / 113卷 / 03期

关键词：

Down syndrome; AOPP-CRP; atherosclerosis;

D O I：

10.1016/j.ijcard.2005.10.019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Murdoch et al. in 1977 called Down syndrome an "atheroma-free model." In this preliminary study, we investigated advanced oxidation protein products (AOPP) ami high-sensitive C-reactive protein (hs-CR-P) in 47 age-matched Down syndrome patients and 20 age-matched healthy controls. In these healthy patients, we detected no new biochemical risk factors for atherosclerosis, such as AOPP and hs-CR-P, so risks are probably considerably lower. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

引用

页码：427 / 429

页数：3

共 15 条

[1]

BAIRD PA, 1988, AM J HUM GENET, V43, P239

[2] Further evidence of inflammation in chronic rheumatic valve disease (CRVD): High levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP) [J].